These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Phase II study of vindesine in hematological malignancies]. Gan To Kagaku Ryoho; 1983 Dec; 10(12):2509-15. PubMed ID: 6580841 [Abstract] [Full Text] [Related]
27. [Phase II study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)]. Tanaka I, Kobayashi T, Shirakawa S, Ikeda Y, Kobayashi M, Yamagata K, Ohta K, Ohno R, Yamada H, Yamada K. Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):493-8. PubMed ID: 3859248 [Abstract] [Full Text] [Related]
28. [Clinical study on the effect of human lymphoblastoid interferon in multiple myeloma]. Takeyama H, Yano K, Kataoka T, Yamamoto M, Emi N, Kodera Y, Kawashima K, Ohno R, Yokomaku S, Kobayashi M. Gan To Kagaku Ryoho; 1983 Sep; 10(9):2043-8. PubMed ID: 6614939 [Abstract] [Full Text] [Related]
30. Human leukocyte (alpha) interferon in metastatic malignant melanoma: the American Cancer Society phase II trial. Krown SE, Burk MW, Kirkwood JM, Kerr D, Morton DL, Oettgen HF. Cancer Treat Rep; 1984 May; 68(5):723-6. PubMed ID: 6722830 [Abstract] [Full Text] [Related]
34. Phase II study of human lymphoblastoid interferon in patients with multiple myeloma. Cox EB, Laszlo J, Krown S, Mintzer D, Sarna G. J Biol Response Mod; 1988 Jun; 7(3):318-25. PubMed ID: 3392554 [Abstract] [Full Text] [Related]
35. [The treatment of renal cell carcinoma with recombinant human leukocyte interferon]. Kawamura J, Yamauchi T, Hashimura T, Yoshida O, Kohnami T, Tomoyoshi T, Ogura K, Fukuyama T, Nakagawa K. Hinyokika Kiyo; 1985 Mar; 31(3):377-86. PubMed ID: 4025077 [Abstract] [Full Text] [Related]
36. Clinical study of recombinant DNA-produced leukocyte interferon (clone A) in a intermittent schedule in cancer patients. Quesada JR, Gutterman JU. J Natl Cancer Inst; 1983 Jun; 70(6):1041-6. PubMed ID: 6190033 [Abstract] [Full Text] [Related]
37. [Clinical experience with alpha and beta interferon in childhood cancer]. Ise T, Ohira M, Takayama J, Hanada M, Muchi H, Fukuma H, Beppu Y, Nomura K. Gan To Kagaku Ryoho; 1984 Sep; 11(9):1855-62. PubMed ID: 6591860 [Abstract] [Full Text] [Related]
38. [Treatment of various malignancies with recombinant IFN-gamma (S-6810). The IFN-gamma Study Group]. Takaku F. Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):645-52. PubMed ID: 3030197 [Abstract] [Full Text] [Related]
39. Human alpha-lymphoblastoid interferon. A phase I study including pharmacokinetics and effects on hematologic stem cells (CFU-GMs). Sarna G, Figlin R, Bryson Y, Garratty E, Myers L, Le Fevre C, Mauritzon N, Cline M. Am J Clin Oncol; 1985 Oct; 8(5):406-12. PubMed ID: 4061375 [Abstract] [Full Text] [Related]
40. [Phase I study of human lymphoblastoid alpha-interferon on malignant tumor]. Furue H. Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):977-83. PubMed ID: 3963861 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]